US Tech 100

19,452.80

0.51%

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

IMNM Immunome Inc

11.47

0.00 (0.00%)

Pre Market

Last Updated: 06:00:00

Delayed by 15 minutes

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Immunome (NASDAQ:IMNM)
Historical Stock Chart
From Oct 2024 to Nov 2024

Immunome (NASDAQ:IMNM)
Historical Stock Chart
From Nov 2023 to Nov 2024

Immunome Inc News

Form 8-K - Current report
Tuesday 29 October 2024 (3 days ago) • Edgar (US Regulatory)

Immunome Presents Compelling Preclinical Data Demonstrating Robust Anti-Tumor Activity for IM-1021
Tuesday 29 October 2024 (3 days ago) • Business Wire

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Tuesday 22 October 2024 (1 week ago) • Edgar (US Regulatory)

Immunome to Present Poster Highlighting Preclinical Evaluation of IM-1021, a ROR1-Targeted Antibody Drug Conjugate, at the 36th EORTC-NCI-AACR Symposium
Friday 18 October 2024 (2 weeks ago) • Business Wire

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers
Tuesday 8 October 2024 (3 weeks ago) • Edgar (US Regulatory)

Immunome Appoints Roee Shahar as Executive Vice President, Commercial
Tuesday 8 October 2024 (3 weeks ago) • Business Wire

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Tuesday 8 October 2024 (3 weeks ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Friday 20 September 2024 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 19 September 2024 (1 month ago) • Edgar (US Regulatory)

Immunome to Present Updated Results for RINGSIDE Phase 2 Trial of AL102 for the Treatment of Desmoid Tumors at the European Society for Medical Oncology (ESMO) Congress 2024
Friday 13 September 2024 (2 months ago) • Business Wire

Immunome to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
Thursday 29 August 2024 (2 months ago) • Business Wire

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Wednesday 21 August 2024 (2 months ago) • Edgar (US Regulatory)

More Immunome Inc News Articles

USOTC

ASII

Accredited Solutions (PK)

Net Savings Link (PK)

Intergrated Cannabis Sol... (PK)

CBD Life Sciences (PK)

NASDAQ

LWLG

Lightwave Logic

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

IMNM Immunome Inc

Immunome Inc News

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

IMNM Immunome Inc

Immunome Inc News

Your Recent History

Company

Business

Popular

Get The App